Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. Oct 1, 2002; 99(20): 12889–12894.
Published online Sep 16, 2002. doi:  10.1073/pnas.192433399
PMCID: PMC130555
Developmental Biology

Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei


To assess the extent of abnormal gene expression in clones, we assessed global gene expression by microarray analysis on RNA from the placentas and livers of neonatal cloned mice derived by nuclear transfer (NT) from both cultured embryonic stem cells and freshly isolated cumulus cells. Direct comparison of gene expression profiles of more than 10,000 genes showed that for both donor cell types ≈4% of the expressed genes in the NT placentas differed dramatically in expression levels from those in controls and that the majority of abnormally expressed genes were common to both types of clones. Importantly, however, the expression of a smaller set of genes differed between the embryonic stem cell- and cumulus cell-derived clones. The livers of the cloned mice also showed abnormal gene expression, although to a lesser extent, and with a different set of affected genes, than seen in the placentas. Our results demonstrate frequent abnormal gene expression in clones, in which most expression abnormalities appear common to the NT procedure whereas others appear to reflect the particular donor nucleus.

The majority of cloned mammals derived by nuclear transfer (NT) die during gestation, display neonatal phenotypes resembling large offspring syndrome (1, 2), often with respiratory and metabolic abnormalities, and have enlarged and dysfunctional placentas (35). For a donor nucleus to support development in a clone, it must be reprogrammed to a state compatible with embryonic development. The transferred nucleus must properly activate genes important for early embryonic development and also adequately suppress differentiation-associated genes that had been transcribed in the original donor cell. Because few clones survive to birth, the question remains whether survivors are normal or merely the least severely affected animals, making it to adulthood despite harboring subtle abnormalities originating from inadequate nuclear reprogramming (6).

Given the long generational time of most animal species cloned, the long-term consequences of cloning on health have been difficult to assess. Evidence that cloned animals retain abnormalities capable of causing severe health consequences has been obtained for mice cloned from Sertoli cells that, in comparison to normally developing controls of the same sex and background, had reduced lifespans and frequent pneumonia and hepatic failure (7). Additionally, mice cloned from cumulus cell donor nuclei were obese with increased body fat and size (8). Because obesity was not passed on to the offspring of the clones it is unlikely to reflect any genetic changes in the clones but instead to reflect epigenetic abnormalities arising from inadequate nuclear reprogramming. Examination of adult clones in other species has been described only for younger animals and limited to physical examinations and blood and urine chemistry (9).

Development of clones derived from embryonic stem (ES) cell nuclei to the blastocyst stage is less efficient than that of clones derived from somatic donor nuclei because the majority of ES cells are in S phase (6), a stage of the cell cycle that is incompatible with survival of clones (10). However, survival to birth or adulthood of blastocysts derived from ES cell donor nuclei is about 10–20 times more efficient than that of clones derived from somatic donor nuclei (11, 12). This striking increase in development rate suggests that less reprogramming is needed for nuclei of embryonically derived cells and that reprogramming is important for postimplantation development. Despite this enhanced developmental rate, it has been argued that epigenetic instability described in ES cells during in vitro culturing (13, 14) makes them a poor choice for NT donors (15). However, this argument is based largely on the expression of imprinted genes known to be particularly affected in ES cells. Nevertheless, common phenotypes, including dramatically overgrown placentas, have been described when using either ES cell or somatic cell donor nuclei for NT (3, 12).

Examination of gene expression in cloned animals has largely been limited to preimplantation embryos for a small number of genes important for early embryogenesis (1618). In clones surviving to birth, the expression of a limited number of imprinted genes has been described, and several are expressed at abnormal levels (14, 15) with some changes reflecting epigenetic, in addition to chromosomal, abnormalities (19) arising in donor cells, in particular during the in vitro culture of ES cell donors. However, apart from about a dozen examined genes, it is not clear to what extent other imprinted gene expression or global gene expression may be abnormal in neonatal clones. Faulty imprinting has been proposed as a candidate for some cloning phenotypes because imprinted genes are frequently involved in fetal and placental growth (20) and are likely resistant to reprogramming because their imprints are established in the germ line and specifically maintained in the embryo (21). Furthermore, in vitro culturing of embryos can lead to a loss of imprinting and large offspring syndrome (22, 23). Because cloned embryos also display phenotypes resembling large offspring syndrome it is possible that some of these phenotypes result from imprinting abnormalities.

We report here the expression profiles of more than 10,000 genes in placentas and livers of neonatal clones from both ES cell and cumulus cell donor nuclei. Our results suggest that many expression abnormalities are common to the NT procedure whereas some reflect the particular donor nucleus. These results further emphasize the severity of placental dysfunction and illustrate abnormalities in clones surviving to birth.

Materials and Methods

RNA Preparation and Array Hybridization.

Cloned mouse neonates were produced by NT from ES and cumulus cell nuclei. Most clones derived from both donor cell types exhibited fetal overgrowth and an enlarged placenta. The average birth and placental weights, respectively, were 1.3 g and 0.09 g for normally fertilized embryos, 2.1 g and 0.32 g for ES cell NT mice (12), and 2.2 g (n = 12) and 0.33 g (n = 14) for cumulus cell NT mice. The distribution of increased placental and birth weights was similar to that seen in our previous study (14). RNA was isolated from a total of 24 placentas and 20 livers, and expression analysis was performed by using Affymetrix (Santa Clara, CA) gene arrays. Two sets of experiments were run by using two different array versions. RNA was isolated from mouse placentas after C-section at term as described (14). The cloning efficiencies for the ES cell NT mice have been reported (12, 14), and the survival rates of the cumulus clones were similar to previous reports (24). Preparation of targets, hybridization, washing, and scanning were carried out with slight modifications to those protocols described (25). A total of 24 placental samples were examined on Affymetrix arrays. In the first set of experiments, the following nine placental samples were hybridized to murine genome U74A version 1 arrays: two 129/Cast normal controls, one B6/DBA2 placenta derived from normal zygotes cultured in vitro to the blastocyst stage before embryo transfer, two 129/Cast placentas derived by ES cell (F1.2–3 line) NT, two 129/Cast placentas derived by cumulus cell NT, and two B6/DBA2 placentas derived by cumulus cell NT. An additional 15 samples were analyzed on murine genome U74A version 2 arrays: five B6/129 normal control placentas (three female, two male), five B6/129 placentas derived by ES cell (V6.5 line) NT, and five DBA2/Cast placentas derived by cumulus cell NT. The version 1 arrays contained 2,608 nonfunctional probe sets of the 12,654 on the array.

Twenty liver samples were analyzed, 10 samples on each array version. The first comparison of version 1 arrays was made by using the following 10 samples: two 129 normally developing mice, three tetraploid embryo complementation mice using a V6.5 ES cell subclone 89 (14), three ES cell NT mice from V6.5 subclone 89, and two ES cell NT mice from a J1 line. In the second set of experiments using array version 2, we used another 10 samples: three normally developing mice (two B6/DBA2 F1, one B6/129 F1), three tetraploid embryo complementation mice using a V6.5 ES cell subclone 23, two ES cell NT mice from V6.5 subclone 23, and two B6/DBA2 F1 cumulus cell NT mice. In most cases the livers were from different conceptuses than the placentas.

Analysis of Array Data.

Intensity values on each array were scaled to the first control array such that plotting the data sets on two axes gave a slope of one and a y intercept of zero. Genes with a calculated expression level below 50 units were set to a value of 50 units. A multiple hypothesis testing correction was performed by using both a multiple testing under dependency false discovery rate (ref. 36; www.math.tau.ac.il/~ybenja/depApr27.pdf) and a Westfall–Young stepdown algorithm family-wise error rate (see ref. 37) when calculating adjusted P values. The expression of many genes varied considerably in the controls. In analysis of the combined data sets, the standard deviation as a percentage of the average expression, or coefficient of variation, for each gene was calculated by using the eight control samples, including the in vitro cultured control. Only those genes with a coefficient of variation of less than 0.25 were included in the final candidate list. This process eliminated sex-specific genes such as Xist and other genes that proved by Northern analysis to have highly variable expression among isogenic controls. The only ES cell NT data used to generate Table Table33 were for the animals derived by NT from the V6.5 ES cell subclones; the J1 line data were excluded. In generating predictors, both weighted voting and k-nearest neighbor algorithms were used.

Table 3
Altered gene expression in livers of clones

Northern Analysis.

Northern analysis was performed as described (14) with the same probes for H19, Peg1/Mest, and Meg1/Grb10. Probes for Vanin-1 and Carbonic anhydrase 2 were generated from IMAGE clones 517746 and 1481304, respectively.


Abnormal Gene Expression Profiles in Placentas of Clones Derived from ES Cell and Cumulus Cell Donors.

Each of the two types of NT placentas was first compared with the controls. Genes showing a 2-fold or more expression difference between the means of the controls and either of the ES cell NT or cumulus cell NT placentas were determined for 15 samples on the more recent array version. Fig. Fig.11A gives a visual comparison of gene expression differences between the three groups of animals. The expression of 286 genes was found to be changed at least 2-fold in cumulus clones as compared with normally fertilized controls and to differ significantly by a Student's t test (P < 0.05). Similarly, dysregulation of 221 genes was detected in ES cell-derived clones. Because many genes might be expected to show significant differences by chance when thousands of genes are examined, we calculated adjusted P values for this data set to account for the large number of genes. Fifty six percent of the genes in this subset were calculated to have an adjusted P value of less than or equal to 0.05 for a false discovery rate. Also, 101 genes in total had an adjusted P value meeting a threshold of 0.05 for a family-wise error rate (probability of at least one error in the group), showing that the differences we observed did not arise by chance. A schematic comparison of genes abnormally expressed in either type of experimental placenta is given in Fig. Fig.11B. Many of the abnormally regulated genes were common to the two types of clones, whereas some were dysregulated either only in cumulus or ES cell donor-derived clones but not in both (Fig. (Fig.1).1). Of the 188 genes with reduced expression in the ES cell NT placentas, 148 (79%) were also reduced in the cumulus cell NT placentas. In total, 76% of the genes showing a 2-fold change in ES cell NT placentas, either up or down relative to controls, also showed a consistent, more than 2-fold change in the placentas of cumulus cell clones. An additional 17% (93% in total) showed a more than 1.5-fold change. These results suggest that the majority of expression abnormalities were generally common to all cloned mice rather than specific to those derived from one particular cell type. The variability between clones appeared higher than between controls but the differences were not statistically significant.

Figure 1
(A) Representation of the expression levels of all genes showing a 2-fold difference in mean expression between any two sample types. Placentas are along the vertical axis and genes along the horizontal axis. Average expression across the 15 samples is ...

To determine the identity of genes most likely to be dysregulated in NT placentas, both data sets were incorporated into the analysis. These data included control RNAs from placentas of both sexes, from placentas of in vitro-cultured embryos, and from both interstrain (Mus musculus × M. musculus) and interspecific (M. musculus × Mus castaneus) F1 samples. Genes showing high variation in the controls were excluded from the candidate list to eliminate genes with altered expression as a result of background variation. Table Table11 is a shortened list of those genes with most altered expression levels. The complete list is available as Table 5, which is published as supporting information on the PNAS web site, www.pnas.org. These candidates were also analyzed with the data from each array version assessed independently. The majority of the genes shown exhibited a consistently altered expression in both sets of experiments.

Table 1
Twenty-five genes that were most significantly (t test, P < 0.05) up- or down-regulated between the indicated groups of placentas

To demonstrate that the overall expression patterns were substantially different between the clones and controls, we generated predictors to classify our samples as has been done to assign tumors to known classes (26). Using classifiers based on 6–10 genes, we were able to correctly remove data corresponding to a given sample, one at a time, and then correctly reassign each of the 24 placental samples to either the control or the clone group based on the remaining samples. These results demonstrate that NT and control placentas have expression profiles that can be readily distinguished.

In addition to comparing the placentas of clones with those of controls, we compared the placentas of the two NT types with each other. We found significant differences between ES cell-derived and cumulus cell-derived clones. However, the number of abnormally expressed genes was about 10-fold less than when the two types of clones were combined and compared with controls. A list of genes showing the greatest fold changes between the two types of clones but little variation in controls are shown in Table Table22 and Table 6, which is published as supporting information on the PNAS web site.

Table 2
Genes differing in their expression levels between the two types of NT placentas are ordered from greatest to least average expression difference for each comparison

Gene Expression in Somatic Lineages of Neonatal Clones.

To determine the status of gene expression in the somatic lineages of cloned mice we analyzed neonatal livers by using two sets of array data. We analyzed gene expression in the livers of five normal mice, seven mice derived by ES cell NT, and two mice derived by NT from cumulus cells. This analysis revealed differences in gene expression between tissues of control and cloned pups derived from ES cell donor nuclei. However, these differences were less pronounced and the affected genes were generally distinct from those affected in the placentas (Table (Table3).3). Livers of the clones derived from cumulus cell donor nuclei also showed abnormalities in gene expression but we were not able to assess the statistical significance of these differences because of insufficient sample size.

We also generated entirely ES cell-derived mice by tetraploid embryo complementation as a comparison for the ES cell NT mice. Because these mice are not generated by NT and do not exhibit overgrown placentas (12), we can use them to further define which expression changes in ES cell NT mice are likely to reflect either the ES cell donor or the NT procedure itself, including possible secondary effects of dysfunctional NT placentas. Six mice derived by tetraploid embryo complementation, from the same ES cell subclones used to generate the NT embryos, were analyzed with arrays. Among the genes affected severely in ES cell NT mice, we screened for gene expression changes in the livers most consistent with being caused either by NT (common changes in just both NT types) or by characteristics of the ES cell donor (common changes in just ES cell-derived livers). As summarized in Table Table3,3, we found genes with expression patterns falling into both of these expression classes, including H19, which was affected specifically in the ES cell-derived animals.

Imprinted Gene Expression in Clones.

We next focused on the expression profiles of imprinted genes in both the placentas and livers of clones. Although H19 was among the most variable genes in ES cell-derived animals, its expression showed no significant variability in either the livers or placentas of cumulus cell-derived clones, confirming previous results (14, 15). In contrast, the expression levels of three other imprinted genes (Dlk, Meg1/Grb10, and Peg1/Mest) in the placentas were similar for both types of clones and were significantly different from controls for both donor cell types (Table (Table4).4). In liver, expression of Peg1/Mest and Meg1/Grb10 was not significantly reduced in the clones, except in pups derived from ES donor cell line subclone 23, which had previously been shown to lack Peg1/Mest expression upon in vitro differentiation (14). Conversely, Cdkn1c (p57) appeared to be elevated in liver but not placenta of cloned pups. When expression of H19, Igf2, Igf2r, and SNRPN in placentas and embryos of both cumulus and ES cell NT mice was tested by using allele-specific assays of F1 Mus/Cast clones, we failed to detect inappropriate activation of the normally silent allele (data not shown), confirming data published by others (15). This finding is consistent with our quantitative analyses and argues that the decreased expression of those imprinted genes is caused by reduced expression of the normally active allele and may not involve the other normally inactive allele. However, our results do not support the claim (15) that abnormal expression of imprinted genes is generally more pronounced in ES cell donor-derived clones than in cumulus cell donor-derived clones. Instead it appears that H19 and Igf2 are exceptional genes whose expression and methylation levels have been shown to be highly sensitive to environmental influences (22, 27, 28) such as in vitro cultivation.

Table 4
Imprinted gene expression

Northern Analysis of Abnormally Expressed Genes.

To confirm the expression levels of several genes analyzed on the arrays, Northern blot analysis was performed with both placental samples used in the array analysis and with additional controls and clones (Fig. (Fig.2).2). Consistent with previous results (14, 15) and our array analysis, H19 expression varied dramatically in placentas of ES cell donor-derived clones (Fig. (Fig.2,2, lanes 19–37) but not in cumulus cell donor-derived clones (Fig. (Fig.2,2, lanes 9–18) and controls (Fig. (Fig.2,2, lanes 1–7). Expression of Meg1/Grb10 and Peg1/Mest, however, were reduced in both cumulus cell- and ES cell-derived clones. We also probed for two nonimprinted genes whose expression levels appeared significantly altered by array analysis. Consistent with the array analyses, Northern hybridization demonstrated that Carbonic anhydrase 2 was up-regulated, with expression levels higher in the ES cell-derived clones than in cumulus cell-derived clones (compare with Tables Tables11 and 5). Northern analysis of Vanin-1 RNA showed reduced expression in clones that was more pronounced in cumulus than in ES cell-derived clones, also in agreement with the array analyses. Of the genes showing expression changes by Northern analysis, only H19 and Igf2 appeared to be similarly affected in both neonatal tissues and the placentas, relative to controls (data not shown).

Figure 2
Northern analysis of several genes dysregulated in NT placentas at term. Lanes 1–6 contain RNA from naturally derived B6/129 controls, whereas the RNAs in lanes 7 and 8 are derived from the placentas from normal B6/129 zygotes ...


In summary, oligonucleotide array expression analyses indicate a pronounced dysregulation of several hundred genes in the placentas of cloned mice, representing at least 4% of the expressed genes. These differences were pronounced, allowing an easy distinction between clones and controls based solely on gene expression profiles. Histological analyses of the placentas of cloned pups have demonstrated a frequent overgrowth of the spongiotrophoblast layer and an increase in the number of glycogen-producing cells (29). Thus, some of the changes in placental gene expression may reflect changes in relative abundance of certain cell types. However abnormal gene expression in the placentas did not correlate with placental size, indicating that these changes in cellular composition are unlikely to account for many of the observed expression changes. Our data show that many factors may contribute to altered gene expression including faulty reprogramming after NT and epigenetic errors inherited from the specific type of donor nucleus. These results are consistent with NT experiments in amphibians, in which the differentiation status of the donor cell has been shown to affect the developmental potential of cloned animals (3034). The data presented here indicate that highly variable gene expression, observed previously for a limited number of genes in both amphibian (34) and mammalian clones (14, 15, 35), affects much of the genome and further emphasizes that many changes are tolerated during cellular differentiation and even in surviving clones. In addition, in vitro-cultivated ES cells have been shown to be epigenetically unstable (13, 14). When used as donors for NT, this instability contributes to widespread dysregulation of imprinted genes in the cloned mice. Cumulus cells are not cultured before NT, yet clones derived from these cells also exhibit abnormal expression levels of many imprinted genes. Thus, in vitro culture cannot be the sole cause of disrupted imprinted gene expression in cloned animals. Because the number of gene expression abnormalities was comparable in clones derived from cumulus cell and ES cell donor nuclei, our results are not consistent with the claim that clones from somatic donor nuclei are more “normal” than those derived from ES cell donors (15).

The altered expression of hundreds of genes in NT placentas may be related to the high mortality rate of cloned embryos during in utero development. Because of the atypical maternal-fetal environment during gestation of cloned embryos, even surviving clones may not be normal at birth and/or later in life. Gene expression changes in livers of cloned pups were less pronounced than in the placentas and affected a largely distinct set of genes. As the trophectoderm is the first lineage to be established in the embryo, eventually giving rise to the placenta, the reduced time period available for reprogramming in this lineage may contribute to the increased relative severity of placental phenotypes. The use of tetraploid embryo complementation to generate mice derived from ES cells as a comparison to those derived by NT provides a means to begin distinguishing phenotypes that are attributable to specific aspects of cloning.

Our results are consistent with the hypothesis that most clones, independent of their cellular origin, may have gene expression abnormalities causing subtle phenotypes (6). Recent studies showing premature death, pneumonia, hepatic failure (7), and obesity (8) in aging cloned mice could be a consequence of these gene expression abnormalities. Interestingly, the cloned mice showing premature death did not show obesity, which could reflect the use of two different somatic donor cell types in these studies. Conclusions about the normalcy of surviving cloned animals therefore should not be based on superficial clinical examinations (9) but rather on detailed molecular analyses of tissues from adult cloned animals.

Supplementary Material

Supporting Tables:


We thank Pablo Tamayo and Matt Tudor for assistance in data analysis. This work was supported by the Victoria and Bradley Geist Foundation, the Kosasa Family Foundation, and the Harold Castle Foundation (to R.Y.) and National Institutes of Health Grants 5-R35-CA44339 and RO1-CA84198 (to R.J.). This work was supported in part by grants from Affymetrix, Inc., and the Bristol-Myers Squibb Company.


nuclear transfer
embryonic stem


1. Young L E, Sinclair K D, Wilmut I. Rev Reprod. 1998;3:155–163. [PubMed]
2. Chavatte-Palmer P, Heyman Y, Renard J P. Gynecol Obstet Fertil. 2000;28:633–642. [PubMed]
3. Wakayama T, Yanagimachi R. Nat Genet. 1999;22:127–128. [PubMed]
4. Hill J R, Roussel A J, Cibelli J B, Edwards J F, Hooper N L, Miller M W, Thompson J A, Looney C R, Westhusin M E, Robl J M, Stice S L. Theriogenology. 1999;51:1451–1465. [PubMed]
5. Hill J R, Burghardt R C, Jones K, Long C R, Looney C R, Shin T, Spencer T E, Thompson J A, Winger Q A, Westhusin M E. Biol Reprod. 2000;63:1787–1794. [PubMed]
6. Rideout W M, III, Eggan K, Jaenisch R. Science. 2001;293:1093–1098. [PubMed]
7. Ogonuki N, Inoue K, Yamamoto Y, Noguchi Y, Tanemura K, Suzuki O, Nakayama H, Doi K, Ohtomo Y, Satoh M, et al. Nat Genet. 2002;30:253–254. [PubMed]
8. Tamashiro K L, Wakayama T, Akutsu H, Yamazaki Y, Lachey J L, Wortman M D, Seeley R J, D'Alessio D A, Woods S C, Yanagimachi R, Sakai R R. Nat Med. 2002;8:262–267. [PubMed]
9. Lanza R P, Cibelli J B, Faber D, Sweeney R W, Henderson B, Nevala W, West M D, Wettstein P J. Science. 2001;294:1893–1894. [PubMed]
10. Wilmut I, Schnieke A E, McWhir J, Kind A J, Campbell K H. Nature (London) 1997;385:810–813. [PubMed]
11. Rideout W M, Wakayama T, Wutz A, Eggan K, Jackson-Grusby L, Dausman J, Yanagimachi R, Jaenisch R. Nat Genet. 2000;24:109–110. [PubMed]
12. Eggan K, Akutsu H, Loring J, Jackson-Grusby L, Klemm M, Rideout W M, 3rd, Yanagimachi R, Jaenisch R. Proc Natl Acad Sci USA. 2001;98:6209–6214. [PMC free article] [PubMed]
13. Dean W, Bowden L, Aitchison A, Klose J, Moore T, Meneses J J, Reik W, Feil R. Development (Cambridge, UK) 1998;125:2273–2282. [PubMed]
14. Humpherys D, Eggan K, Akutsu H, Hochedlinger K, Rideout W M, 3rd, Biniszkiewicz D, Yanagimachi R, Jaenisch R. Science. 2001;293:95–97. [PubMed]
15. Inoue K, Kohda T, Lee J, Ogonuki N, Mochida K, Noguchi Y, Tanemura K, Kaneko-Ishino T, Ishino F, Ogura A. Science. 2002;295:297. [PubMed]
16. Daniels R, Hall V, Trounson A O. Biol Reprod. 2000;63:1034–1040. [PubMed]
17. Daniels R, Hall V J, French A J, Korfiatis N A, Trounson A O. Mol Reprod Dev. 2001;60:281–288. [PubMed]
18. Wrenzycki C, Wells D, Herrmann D, Miller A, Oliver J, Tervit R, Niemann H. Biol Reprod. 2001;65:309–317. [PubMed]
19. Eggan K, Rode A, Jentsch I, Samuel C, Hennek T, Tintrup H, Zevnik B, Erwin J, Loring J, Jackson-Grusby L, et al. Nat Biotechnol. 2002;20:455–459. [PubMed]
20. Tilghman S M. Cell. 1999;96:185–193. [PubMed]
21. Brandeis M, Kafri T, Ariel M, Chaillet J R, McCarrey J, Razin A, Cedar H. EMBO J. 1993;12:3669–3677. [PMC free article] [PubMed]
22. Khosla S, Dean W, Brown D, Reik W, Feil R. Biol Reprod. 2001;64:918–926. [PubMed]
23. Young L E, Fernandes K, McEvoy T G, Butterwith S C, Gutierrez C G, Carolan C, Broadbent P J, Robinson J J, Wilmut I, Sinclair K D. Nat Genet. 2001;27:153–154. [PubMed]
24. Wakayama T, Perry A C, Zuccotti M, Johnson K R, Yanagimachi R. Nature (London) 1998;394:369–374. [PubMed]
25. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander E S, Golub T R. Proc Natl Acad Sci USA. 1999;96:2907–2912. [PMC free article] [PubMed]
26. Golub T R, Slonim D K, Tamayo P, Huard C, Gaasenbeek M, Mesirov J P, Coller H, Loh M L, Downing J R, Caligiuri M A, et al. Science. 1999;286:531–537. [PubMed]
27. Doherty A S, Mann M R, Tremblay K D, Bartolomei M S, Schultz R M. Biol Reprod. 2000;62:1526–1535. [PubMed]
28. Biniszkiewicz D, Gribnau J, Ramsahoye B, Gaudet F, Eggan K, Humpherys D, Mastrangelo M A, Jun Z, Walter J, Jaenisch R. Mol Cell Biol. 2002;22:2124–2135. [PMC free article] [PubMed]
29. Tanaka S, Oda M, Toyoshima Y, Wakayama T, Tanaka M, Yoshida N, Hattori N, Ohgane J, Yanagimachi R, Shiota K. Biol Reprod. 2001;65:1813–1821. [PubMed]
30. Briggs R, King T. J Morphol. 1957;100:269–302.
31. Gurdon J B, Laskey R A, Reeves O R. J Embryol Exp Morphol. 1975;34:93–112. [PubMed]
32. DiBerardino M A. Differentiation. 1980;17:17–30. [PubMed]
33. McKinnell R G, Di Berardino M A. BioScience. 1999;49:875–885.
34. Byrne J A, Simonsson S, Gurdon J B. Proc Natl Acad Sci USA. 2002;99:6059–6063. [PMC free article] [PubMed]
35. De Sousa P, Winger Q, Hill J R, Jones K, Watson A J, Westhuisen M E. Cloning. 1999;1:63–69. [PubMed]
36. Benjamini Y, Yekutieli D. Thesis. Tel Aviv: Tel Aviv University; 2001.
37. Dudoit S, Yang Y H, Callow M J, Speed T P. University of California, Berkeley Technical Report 578. 2000. http://www.stat.berkeley.edu/tech-reports/ , e-Print Archive, http://www.stat.berkeley.edu/tech-reports/(Univ. of California, Berkeley). (Univ. of California, Berkeley).

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...